TKNO — Alpha Teknova, Inc.

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1850902 ·
Last close
$7.34
Market Cap
$394.07M
52W High
$7.84
52W Low
$3.89
ADV30
219,078
Next earnings
2026-11-05
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 12,185,000 4,885,000 -2,890,000 -3,170,000 95,878,000 6,004,000 33,278,000
Mar 2026 11,077,000 3,784,000 -4,298,000 -4,555,000 98,657,000 4,306,000 33,733,000
Dec 2025 9,984,000 3,244,000 -4,609,000 -4,758,000 103,584,000 5,912,000 34,809,000
Sep 2025 10,454,000 3,206,000 -4,017,000 -4,286,000 107,625,000 3,204,000 34,975,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,272,000
Investing CF
$8,633,000
Financing CF
$367,000
CapEx
$-1,081,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.31
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-143,515,000
Inventory
$6,911,000
Receivables
$5,408,000
ST Investments
$11,432,000
EBIT TTM
$-15,803,000
Pretax Income TTM
$-16,675,000
Interest Exp TTM
$872,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$43,700,000
EBITDA
$-8,973,000
Free Cash Flow
$-735,250
Enterprise Value
$404,043,712
Total Cash
$17,436,000
Total Debt
$27,408,000
Shares Out
53,688,246
Trailing EPS
$-0.31
Book Value
$1.17
ROE
-24.2%
ROA
-9.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 40,520,000 -16,976,000 -17,259,000 103,584,000 34,809,000 -8,646,000
Dec 2024 37,745,000 -26,146,000 -26,745,000 118,769,000 36,375,000 -12,391,000
Dec 2023 36,684,000 -31,199,000 -36,780,000 128,587,000 38,551,000 -18,814,000
Dec 2022 41,420,000 -28,858,000 -47,468,000 152,261,000 52,376,000 -27,400,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.19

Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $7.46 · call volume: 33 · put volume: 20

Peers — same industry

TickerNameMarket CapLastDaily %
NNNN Anbio Biotechnology $346.74M $7.90
NRC NRC HEALTH $485.29M $21.92
MYGN MYRIAD GENETICS INC $291.73M $3.05
OABI OmniAb, Inc. $684.79M $4.71
ACHV ACHIEVE LIFE SCIENCES, INC. $817.05M $7.94

News headlines (Yahoo Finance, 1h cache)

Alpha Teknova Q2 Earnings Call Highlights
2026-08-06 06:03 · Yahoo
Alpha Teknova Inc (TKNO) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ...
2026-08-06 05:10 · Yahoo
Teknova Reports Second Quarter 2026 Financial Results
2026-08-05 20:01 · Yahoo
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
2026-05-09 14:23 · Yahoo
Alpha Teknova Q1 Earnings Call Highlights
2026-05-07 07:24 · Yahoo
Alpha Teknova, Inc. Q1 2026 Earnings Call Summary
2026-05-07 00:37 · Yahoo
Teknova Reports First Quarter 2026 Financial Results
2026-05-06 20:01 · Yahoo
Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
2026-04-22 20:01 · Yahoo
Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand
2026-08-07 13:08 · Yahoo
Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference
2026-08-20 02:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.